Novo Nordisk
Victoza data shows promise for early setting
September 13, 2011Research and Development, Sales and Marketing Novo Nordisk, Victoza
New data for Novo Nordisk’s Victoza could help the drug’s chances of being used in an earlier setting for type …
Novo Nordisk invests €134m in Danish facility
June 24, 2011Manufacturing and Production Novo Nordisk, biologics, pharma manufacturing news
Novo Nordisk plans to invest almost 1 billion Danish kroner (134 million euros) in a new biologics manufacturing facility at …
New product can overtake Lantus, says Novo leader
May 11, 2011Sales and Marketing Novo Nordisk, degludec, diabetes, insulin
Novo Nordisk’s new insulin product can eclipse Sanofi’s Lantus within just a few years of its launch, according to Novo’s …
Novo’s diabetes drug Victoza approved in China
March 16, 2011Sales and Marketing Glucagon-Like Peptide-1, Novo Nordisk, Victoza, diabetes in China, liraglutide, type 2 diabetes
Novo Nordisk’s injectable diabetes drug Victoza has been given regulatory approval in China. The Chinese State Food and Drug Administration …
Pharma-NHS diabetes project begins
February 9, 2011Sales and Marketing AstraZeneca, Lilly UK, MSD, NHS, Nottingham, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, joint working
A joint venture between the NHS, charities and the pharma sector has begun in Nottingham to help treat the city’s …
Diabetes drugs show promise in Alzheimer’s
January 17, 2011Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide
Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …
GSK’s Dr Anne Phillips moves to Novo Nordisk
January 4, 2011Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing
Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …
Novo to develop oral insulin
December 22, 2010Research and Development Emisphere, Novo Nordisk, diabetes, insulin, oral insulin, type I diabetes
Novo Nordisk is to develop an oral formulation of insulin with US biotech company Emisphere Technologies. The New Jersey-based biotech …
Novo rebuked after diabetes promotion breaches Code
December 16, 2010Medical Communications ABPI, ABPI Code of Practice, Grunenthal, Napp Pharmaceuticals, Novo Nordisk, PMCPA, diabetes, diabetes drug marketing, lilly
Novo Nordisk been ‘named and shamed’ in health trade journal advertisements this week for breaching the ABPI Code of Practice. …
Novo Nordisk invests $73m to boost diabetes drug production
October 8, 2010Manufacturing and Production Novo Nordisk, diabetes, insulin
Novo Nordisk has announced another major expansion of its manufacturing capacity for diabetes products, setting aside $73 million to expand …
Digital Pharma: Novo launches insulin dosing app
September 17, 2010Medical Communications, Sales and Marketing Digital Pharma blog, Novo Nordisk, app, diabetes, iphone
Novo Nordisk has launched an iPhone app for US healthcare professionals that enables to them look up dosing guidelines for …
Novo expands diabetes research in China
September 16, 2010Research and Development China, Novo Nordisk, diabetes
Diabetes is at the core of Novo Nordisk’s latest investment in China, where the company plans to more than double …
Low dose Victoza on track for NICE approval
September 10, 2010Sales and Marketing NICE, Novo Nordisk, Victoza
Novo Nordisk is on track to receive NICE approval for its type II diabetes drug Victoza, but will still have …
Victoza lifts Novo Nordisk
August 9, 2010Sales and Marketing 2010 financials, Novo Nordisk, Q2
Novo Nordisk has posted a set of healthy results following strong sales from its insulin range and newly launched diabetes …
Novo agrees price cut deal with Greece
June 16, 2010Sales and Marketing Greece, Novo Nordisk, insulin, pricing
Novo Nordisk has agreed to resume supply of its insulins to the Greek market after pulling them last month as …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
